Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous lidocaine on propofol-induced loss of consciousness dose requirements
ChiCTR2100045063Phase 4Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Half effective dose (EC50) of propofol for loss of consciousness and Ninety-fifth percentile effective dose (EC95) of propofol for loss of consciousness. Started Apr 2021; status: recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ChiCTR2100045063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045063.